Ilsa Coleman

Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect

Nolwenn LeMeur, Daniel W Lin, Beatrice S Knudsen, 2010, Clinical Cancer Research.

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Hamid Bolouri, Jay Shendure, Min Fang, 2016 .

Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.

Madhuchhanda Bhattacharjee, Robert A Sikes, P. Nelson, 2009, Cancer research.

Proteome and transcriptome profiles of a Her2/Neu‐driven mouse model of breast cancer

Yan Liu, Pei Wang, Jeffrey R. Whiteaker, 2011, Proteomics. Clinical applications.

Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Judith Campisi, Lawrence True, P. Nelson, 2012, Nature Medicine.

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

Stephen J. Salipante, Deborah A. Nickerson, Jay Shendure, 2011, Proceedings of the National Academy of Sciences.

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation

Daniel Bottomly, Beth Wilmot, Shannon McWeeney, 2013, PloS one.

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

Ming Yu, Colin C. Pritchard, Stephen J. Salipante, 2014, Nature Communications.